Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

78 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and safety of subcutaneous trastuzumab and intravenous trastuzumab as part of adjuvant therapy for HER2-positive early breast cancer: Final analysis of the randomised, two-cohort PrefHer study.
Pivot X, Verma S, Fallowfield L, Müller V, Lichinitser M, Jenkins V, Sánchez Muñoz A, Machackova Z, Osborne S, Gligorov J; PrefHer Study Group. Pivot X, et al. Among authors: sanchez munoz a. Eur J Cancer. 2017 Nov;86:82-90. doi: 10.1016/j.ejca.2017.08.019. Epub 2017 Sep 28. Eur J Cancer. 2017. PMID: 28963915 Free article. Clinical Trial.
Maintenance treatment in metastatic breast cancer.
Sánchez-Muñoz A, Pérez-Ruiz E, Ribelles N, Márquez A, Alba E. Sánchez-Muñoz A, et al. Expert Rev Anticancer Ther. 2008 Dec;8(12):1907-12. doi: 10.1586/14737140.8.12.1907. Expert Rev Anticancer Ther. 2008. PMID: 19046111 Review.
Targeted therapy of metastatic breast cancer.
Sánchez-Muñoz A, Pérez-Ruiz E, Jiménez B, Ribelles N, Márquez A, García-Ríos I, Alba Conejo E. Sánchez-Muñoz A, et al. Clin Transl Oncol. 2009 Oct;11(10):643-50. doi: 10.1007/s12094-009-0419-6. Clin Transl Oncol. 2009. PMID: 19828406 Review.
Cross-sensitivity between taxanes in patients with breast cancer.
Sánchez-Muñoz A, Jiménez B, García-Tapiador A, Romero-García G, Medina L, Navarro V, González-Sánchez LA, Alba E. Sánchez-Muñoz A, et al. Clin Transl Oncol. 2011 Dec;13(12):904-6. doi: 10.1007/s12094-011-0753-3. Clin Transl Oncol. 2011. PMID: 22126735
A randomized phase II trial of platinum salts in basal-like breast cancer patients in the neoadjuvant setting. Results from the GEICAM/2006-03, multicenter study.
Alba E, Chacon JI, Lluch A, Anton A, Estevez L, Cirauqui B, Carrasco E, Calvo L, Segui MA, Ribelles N, Alvarez R, Sanchez-Muñoz A, Sanchez R, Garcia-Asenjo JA, Rodriguez-Martin C, Escudero MJ, Albanell J. Alba E, et al. Among authors: sanchez munoz a, sanchez r. Breast Cancer Res Treat. 2012 Nov;136(2):487-93. doi: 10.1007/s10549-012-2100-y. Epub 2012 Oct 9. Breast Cancer Res Treat. 2012. PMID: 23053638 Clinical Trial.
Tumor histological subtyping determined by hormone receptors and HER2 status defines different pathological complete response and outcome to dose-dense neoadjuvant chemotherapy in breast cancer patients.
Sánchez-Muñoz A, Plata-Fernández Y, Fernández M, Jaén-Morago A, Fernández-Navarro M, de la Torre-Cabrera C, Ramirez-Tortosa C, Pascual J, Alba E, Sánchez-Rovira P. Sánchez-Muñoz A, et al. Among authors: sanchez rovira p. Clin Transl Oncol. 2014 Jun;16(6):548-54. doi: 10.1007/s12094-013-1116-z. Epub 2013 Oct 2. Clin Transl Oncol. 2014. PMID: 24085576 Clinical Trial.
Machine learning and natural language processing (NLP) approach to predict early progression to first-line treatment in real-world hormone receptor-positive (HR+)/HER2-negative advanced breast cancer patients.
Ribelles N, Jerez JM, Rodriguez-Brazzarola P, Jimenez B, Diaz-Redondo T, Mesa H, Marquez A, Sanchez-Muñoz A, Pajares B, Carabantes F, Bermejo MJ, Villar E, Dominguez-Recio ME, Saez E, Galvez L, Godoy A, Franco L, Ruiz-Medina S, Lopez I, Alba E. Ribelles N, et al. Among authors: sanchez munoz a. Eur J Cancer. 2021 Feb;144:224-231. doi: 10.1016/j.ejca.2020.11.030. Epub 2020 Dec 26. Eur J Cancer. 2021. PMID: 33373867
78 results